中国临床肿瘤学会（CSCO）肿瘤微创外科专家委员会主任委员；国际结直肠癌协会副主席，中国分会主席；上海市疾病控制中心肿瘤外科和跨学科诊治专业委员会主任委员；中国转移性肝癌专业委员会副主任委员;上海市医师协会普外分会肛肠外科组组长；
Chairman of the Expert Committee on
Minimally Invasive Surgery of CSCO; Vice President of the International
Colorectal Cancer Club, Chairman of the China Chapter; Chairman of the Expert Committee
on Surgical Oncology and Interdisciplinary Diagnosis and Treatment of Shanghai
Municipal Center for Disease Control; Deputy Director of the Expert Committee
on Metastatic Liver Cancer of China; Team leader of the Department of Anorectal
Surgery, Branch of Shanghai Medical Doctor Association.
1、PIK3CA
and TP53 mutations predict overall survival of stage II/III colorectal cancer
patients（2018.02，World J Gastroenterol，IF：3.365）
2、Preliminary
efficacy of video-assisted anal fistula treatment for complex anal fistula（2015.12，中华胃肠外科杂志）
3、PPP1R12A
Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving
Oxaliplatin-Based Chemotherapy（2015.05，Mediators
Inflamm，IF：3.23）
4、PIK3C2G
copy number is associated with clinical outcomes of colorectal cancer patients
treated with oxaliplatin（2015.01，Int
J Clin Exp Med，IF：1.075）
5、2017年主译《肛肠良性疾病诊断与治疗》
